1-110601794-ATG-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_004974.4(KCNA2):c.*1487_*1488delCA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.063 in 803,640 control chromosomes in the GnomAD database, including 508 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.068 ( 461 hom., cov: 0)
Exomes 𝑓: 0.062 ( 47 hom. )
Consequence
KCNA2
NM_004974.4 3_prime_UTR
NM_004974.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.391
Publications
0 publications found
Genes affected
KCNA2 (HGNC:6220): (potassium voltage-gated channel subfamily A member 2) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, members of which allow nerve cells to efficiently repolarize following an action potential. The coding region of this gene is intronless, and the gene is clustered with genes KCNA3 and KCNA10 on chromosome 1. [provided by RefSeq, Jul 2008]
KCNA2 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 32Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 1-110601794-ATG-A is Benign according to our data. Variant chr1-110601794-ATG-A is described in ClinVar as [Benign]. Clinvar id is 1251556.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.152 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0678 AC: 9194AN: 135554Hom.: 461 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
9194
AN:
135554
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0620 AC: 41387AN: 668038Hom.: 47 AF XY: 0.0628 AC XY: 20046AN XY: 318978 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
41387
AN:
668038
Hom.:
AF XY:
AC XY:
20046
AN XY:
318978
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
2227
AN:
13830
American (AMR)
AF:
AC:
387
AN:
5102
Ashkenazi Jewish (ASJ)
AF:
AC:
1178
AN:
8500
East Asian (EAS)
AF:
AC:
910
AN:
14012
South Asian (SAS)
AF:
AC:
799
AN:
12080
European-Finnish (FIN)
AF:
AC:
923
AN:
9572
Middle Eastern (MID)
AF:
AC:
187
AN:
1734
European-Non Finnish (NFE)
AF:
AC:
32823
AN:
577342
Other (OTH)
AF:
AC:
1953
AN:
25866
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.345
Heterozygous variant carriers
0
2273
4546
6820
9093
11366
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0679 AC: 9204AN: 135602Hom.: 461 Cov.: 0 AF XY: 0.0682 AC XY: 4453AN XY: 65254 show subpopulations
GnomAD4 genome
AF:
AC:
9204
AN:
135602
Hom.:
Cov.:
0
AF XY:
AC XY:
4453
AN XY:
65254
show subpopulations
African (AFR)
AF:
AC:
5320
AN:
34200
American (AMR)
AF:
AC:
580
AN:
13444
Ashkenazi Jewish (ASJ)
AF:
AC:
265
AN:
3328
East Asian (EAS)
AF:
AC:
256
AN:
4458
South Asian (SAS)
AF:
AC:
127
AN:
4066
European-Finnish (FIN)
AF:
AC:
309
AN:
8344
Middle Eastern (MID)
AF:
AC:
23
AN:
274
European-Non Finnish (NFE)
AF:
AC:
2163
AN:
64728
Other (OTH)
AF:
AC:
111
AN:
1884
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
323
646
970
1293
1616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.